News
on
|
Research Feature
Through an adaptive research trial, doctors and patients from 30 U.S. study locations are working together to study if five new medications can help patients with severe asthma by altering the underlying biology of this airway disease. As Erin Routh prepares to walk in winter weather, she does more than put on a jacket, hat, and gloves. The 46-year...
|
Statement
On World Asthma Day, the National Institutes of Health reaffirms its commitment to research to improve the lives of people with asthma. More than 25 million people in the United States have asthma , including 5.1 million children, according to the Centers for Disease Control and Prevention. This chronic lung disease can reduce quality of life...
|
News Release
Updates to six key areas of asthma care focus on improving diagnosis, management and treatment The National Institutes of Health today announced 19 recommendations in six key areas of asthma diagnosis, management and treatment. The new guidance, published in the Journal of Allergy and Clinical Immunology , represents the first updates to federal...
|
Research Feature
Might pave the way for new and improved treatments for a wide variety of respiratory diseases Maps may be great tools for helping you find your way around unfamiliar places, but in the future, a new type of map well might help save your life. Welcome to the Molecular Atlas of Lung Development Program, or LungMAP, a historic effort to help...
|
News Release
“Low eosinophil” biomarkers found in nearly three-quarters of people with mild persistent asthma A study of nearly 300 patients with mild persistent asthma found that inhaled steroids— long considered the gold standard for asthma treatment —were no more effective than placebo in nearly three-fourths of the study patients, all over age 12. Inhaled...
|
Statement
On World Asthma Day 2019, the National Institutes of Health stands with patients, families, advocates, researchers and health care professionals around the globe to raise awareness about this common chronic respiratory disease. In 2016, asthma affected 26 million Americans and nearly 340 million people worldwide, according to the Global Burden of...
|
Research Features
Here’s a sobering thought: Nearly half of Americans with severe asthma do not respond to conventional drugs, leaving them with few ways to minimize the often-debilitating symptoms of the chronic disease. But researchers at NHLBI have developed a new treatment that has the potential to dramatically change that: A synthetic peptide that mimics the...